Health Care

TALi Digital’s (TD1) partnership with Times Group of India has gone live to the Indian consumer market ahead of schedule.

AnteoTech (ADO) has received Conformitè Europëenne (CE) Mark registration for its rapid test platform and COVID-19 test.

Imugene (IMU) presented key findings from its HER-Vaxx immunotherapy and CF33 oncolytic virus programs at the American Association for Cancer Research’s annual meeting.

ResApp Health (RAP) has received firm commitments to raise $5.5 million through a placement.

Medical tech support provider Opyl (OPL) has completed an off-market share buy-back facility for eligible shareholders who held unmarketable parcels in the company

Universal Biosensors (UBI) has entered an exclusive agreement with U.S.-based Lubris Biopharma for the supply of Lubricin for UBI’s diagnostic products.

Kazia Theraputics (KZA) has released data from its ongoing phase two study of its paxalisib candidate in glioblastoma — the most common and

Medical device company Visioneering Technologies (VTI) has closed its security purchase plan after raising more than expected.

Immutep (IMM) has received Fast Track designation in the U.S.

Clinical-stage oncology company PharmAust (PAA) has received a research and development (R&D) rebate of just over $750,000 through the R&D Tax Incentive Scheme.